---
category: news
title: "Renalytix AI plc (“RenalytixAI” or the “Company”) Full Year Report"
excerpt: "(GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care,"
publishedDateTime: 2020-10-27T07:39:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/renalytix-ai-plc-renalytixai-or-the-company-full-year-report-1029724921"
webUrl: "https://markets.businessinsider.com/news/stocks/renalytix-ai-plc-renalytixai-or-the-company-full-year-report-1029724921"
type: article
quality: 49
heat: 49
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI
  - AI in Healthcare

secured: "WfAK5ERaMF2+iReX6SMjo7xC7KZ5ddolgZtQHK8vbC5OzbVkXxIWuNUZXbRMbOGFY/lB0lcSTxzd91Rn3AsP3rt6nFtuhWEqCxnkqu6lGbn09QKDaraeKSK3D58UxL/k7pJiNwicebJOaosoe0vp1G5NkbgYg8CzWsVWiAesBayS8zHgart9rLkRX4gaeCVtiYp6KojwAZ9P+75VZ/2gi+D1v0zJkyflQPVp3czjwNxnYtDGAvTVl5/8kHaBeeyjrjeHAAqt0VSvH5RBxh4iaNJDJi+UNSgiOplfpabCi6USXW7WyZL4aCYz2zU7FYh2Lk7H9U3luCJuKq4TN7dqGR/oi6qQgwl/+GL0Rb0kKgE=;ROFBSBoVdLmK82o3BUhzIA=="
---

